This is a great business, I think it is lacking leadership and anyone that can really drive the revenue with deal flow. The recent placement was a gift, a fee grab and disappointing as shareholders we didn't get look in.
At the end of the day, the approvals they have will flow to all they will need, as getting it allowed into the human body is the biggest hurdle.
If they can get out there and market it right and not wait for the market to come to them. This is going to fly.
Add to My Watchlist
What is My Watchlist?
